Commercial Services Healthcare Sector

4D Molecular Therapeutics

Market Cap: US$161.7m

A late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.

Voyager Therapeutics

Market Cap: US$161.6m

A biotechnology company, focuses on the human genetics for the cure of neurological diseases.

Anika Therapeutics

Market Cap: US$161.2m

A joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.

Puma Biotechnology

Market Cap: US$160.6m

A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

Race Oncology

Market Cap: AU$246.7m

A clinical stage biopharmaceutical company, focuses on addressing the unmet needs of cancer patients for damaging treatments.

LENSAR

Market Cap: US$159.9m

A commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System.

Lineage Cell Therapeutics

Market Cap: US$159.6m

A clinical-stage biotechnology company, develops novel cell therapies for neurological and ophthalmic conditions in the United States and internationally.

Diaceutics

Market Cap: UK£117.5m

A diagnostic commercialisation company, provides data, data analytics, and implementation services for pharma and biotech companies.

Zentek

Market Cap: CA$217.0m

Engages in the research and development of graphene and related nanomaterials in Canada.

Cybin

Market Cap: US$157.1m

A clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions.

Esperion Therapeutics

Market Cap: US$156.6m

A pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States.

hVIVO

Market Cap: UK£115.7m

Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.

EKF Diagnostics Holdings

Market Cap: UK£113.7m

Engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally.

Joint

Market Cap: US$153.0m

Operates and franchises chiropractic clinics in the United States.

Profound Medical

Market Cap: CA$208.9m

Operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland.

Pro-Dex

Market Cap: US$150.8m

Designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide.

Longduoduo

Market Cap: US$149.8m

Together its subsidiaries, provides preventive healthcare solutions in the People’s Republic of China.

Alpha Cognition

Market Cap: US$146.4m

A biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada.

BioAge Labs

Market Cap: US$145.6m

A biopharmaceutical company that develops therapeutic product candidates for metabolic diseases.

Wellgistics Health

Market Cap: US$145.4m

Engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States.

Avacta Group

Market Cap: UK£107.2m

Develops cancer drugs and in vitro diagnostics in the United Kingdom, France, North America, South Korea, rest of Europe, and internationally.

Liminatus Pharma

Market Cap: US$144.6m

Operates as a clinical-stage immuno-oncology company that develops novel cancer therapies.

Exagen

Market Cap: US$144.2m

Designs, develops, and commercializes various testing products under the AVISE brand in the United States.

TerrAscend

Market Cap: CA$196.1m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Cogstate

Market Cap: AU$219.4m

A neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research.

Rapid Micro Biosystems

Market Cap: US$141.4m

A life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally.

EUDA Health Holdings

Market Cap: US$139.7m

Operates as a healthcare specialty company.

Scancell Holdings

Market Cap: UK£101.7m

A clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease.

Eupraxia Pharmaceuticals

Market Cap: CA$188.6m

A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.

NeOnc Technologies Holdings

Market Cap: US$137.4m

A clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies.

ALT5 Sigma

Market Cap: US$137.4m

Provides blockchain-powered technologies worldwide.

Instil Bio

Market Cap: US$137.2m

A clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies.

Atlantic International

Market Cap: US$136.6m

Operates as a staffing company servicing the commercial, professional, finance, direct placement, and managed service provider verticals.

Aclaris Therapeutics

Market Cap: US$136.4m

A clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States.

Kindly MD

Market Cap: US$136.3m

A healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services.

Compugen

Market Cap: US$135.6m

A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.